The Journal of Antibiotics
Online ISSN : 1881-1469
Print ISSN : 0021-8820
ISSN-L : 0021-8820
LIPSTATIN, AN INHIBITOR OF PANCREATIC LIPASE, PRODUCED BY STREPTOMYCES TOXYTRICINI
I. PRODUCING ORGANISM, FERMENTATION, ISOLATION AND BIOLOGICAL ACTIVITY
E. K. WEIBELP. HADVARYE. HOCHULIE. KUPFERH. LENGSFELD
Author information
JOURNAL FREE ACCESS

1987 Volume 40 Issue 8 Pages 1081-1085

Details
Abstract
Lipstatin, a new and very potent inhibitor of pancreatic lipase (the key enzyme of intestinal fat digestion) was isolated from Streptomyces toxytricini. Lipstatin contains a β-lactone structure that probably accounts for the irreversible lipase inhibition. The IC50 of lipstatin for pancreatic lipase is 0.14 μM. In mice triolein absorption was dose-dependently inhibited by lipstatin, whereas oleic acid was absorbed normally. Other pancreatic enzymes, such as phospholipase A2 and trypsin, were not inhibited even at an inhibitor concentration of 200 μM.
Content from these authors
© Japan Antibiotics Research Association
Next article
feedback
Top